Inari Raised $208M, Aetion Secured $110M, and More Boston Tech News

May 17, 2021
photo: inari / twitter

In addition to being a lucrative time for venture funding, Boston tech companies made several new moves last week. Read on to find out these startups’ latest developments. This is the Built In Boston weekly refresh.

Inari secured $208MValued at $1.2 billion following its latest injection of funding, this Cambridge-based biotech company is advancing its platform and furthering its work. Inari developed a way to manipulate the genetics of seeds in an effort to make crops viable in different regions. Flagship Pioneering and existing investors led the round. [Built In Boston]

Aetion raised $110MIts platform gathers data to provide medical professionals with critical product insights to help improve patient care. With the new funding from its Series C led by Warburg Pincus, Aetion is planning to further its platform, fuel international expansion in Europe and Asia and grow its commercial team. It’s currently hiring for positions based out of its Boston office. [Built In Boston]

Boston Tech Quote of the Week

“We have the advantage of designing this space with a post-COVID world in mind and we will have the majority of people who are based in Boston coming to the Whoop office regularly. The days of having an office that people feel obligated to go to are over, and our goal is to create a place that is exciting where people truly want to come together.” —Will Ahmed, Whoop founder and CEO

Whoop is moving its HQ and building out its teamThe company built a wearable wristband meant to monitor a user’s health surrounding sleep and fitness. Its new 121,000-square-foot headquarters in Kenmore Square will house 1,000 new employees across departments like engineering, data science, R&D, marketing and product when it opens next year. [Built In Boston]

Ginkgo Bioworks to go public via SPACAnother company is moving to the public sector through merging with a special purpose acquisition company. By joining Soaring Eagle Acquisition, synthetic biology unicorn Gingko will reach a $15 billion valuation. The capital from the merge will go toward scaling its platform and hiring across dozens of Boston-based science and tech roles. [Built In Boston]

Euclid pulled in $8MFocusing on improving care for those with cardiovascular disease, this healthtech company grabbed fresh Series A funding for its AI-powered detection software. The round was led by investors and will help Euclid to continue developing its tech. [Cardiovascular Business]

Boston startup guides

Best Companies to Work for in Boston
Coolest Tech Offices in Boston
Best Perks at Boston Tech Companies
Women in Boston Tech